Nano Covax COVID-19 vaccine (Photo: vneconomy.vn) Hanoi (VNA) – As many as 554 volunteersjoining the second-stage human trials of home-grown Nano Covax COVID-19 vaccinegot the second shots over the past 14 days.
Associate Prf., Dr. Chu Van Men, Director of theMilitary Medical University’s Centre for Clinical Trials and Bioequivalence,said on April 8 that among the volunteers, 278 received the jabs from theuniversity, while 276 others in Ben Luc district, the Mekong Delta province ofLong An, were vaccinated by HCM City-based Pasteur Institute.
After the injection, the volunteers exhibitedsymptoms such as light fever, injection site pain, muscle aches, joint pain andfatigue, which did not require medical intervention. They are now in stableconditions.
A preliminary report on testing results is scheduledto be issued this May.
The third phase of human trials is expected to cover10,000 – 15,000 people in both Vietnam and other countries.
The first-stage trials of Nano Covax showed that thevaccinated volunteers have had antibodies against the UK variant (B117). Phase2 focuses on seeking antibodies against the UK and South Africa variants,according to Men.
Navo Covax, developed by the Nanogen PharmaceuticalBiotechnology JSC, is the first COVID-19 vaccine of Vietnam to be tested inclinical trials.
The country also has other COVID-19 candidatevaccines under development: IVAC from the Institute of Vaccines and MedicalBiologicals, VABIOTECH from the Company for Vaccine and Biological ProductionNo 1, and POLYVAC from the Centre for Research and Production of Vaccines andBiologicals.
Vietnam expects to have the first batch oflocally-produced COVID-19 vaccines at the end of the third quarter of 2021./.
